Cargando…

Systemic interleukin 12 displays anti-tumour activity in the mouse central nervous system.

In various systemic cancers, interleukin 12 (IL-12) induces anti-tumour immunity mediated by T lymphocytes and natural killer cells. To determine whether IL-12 has anti-tumour activity against malignant gliomas in the central nervous system (CNS), which is considered to be an immunologically privile...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kishima, H., Shimizu, K., Miyao, Y., Mabuchi, E., Tamura, K., Tamura, M., Sasaki, M., Hakakawa, T.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group\|1 1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2063094/ https://www.ncbi.nlm.nih.gov/pubmed/9716025

Ejemplares similares

Monoclonal antibody ONS-M21 recognizes integrin α3 in gliomas and medulloblastomas
por: Kishima, H, et al.
Publicado: (1999)

Usefulness of a Mouse Myelin Basic Protein Promoter for Gene Therapy of Malignant Glioma: Myelin Basic Protein Promoter Is Strongly Active in Human Malignant Glioma Cells
por: Miyao, Yasuyoshi, et al.
Publicado: (1997)

Infectious Retrovirus Is Inactivated by Serum but Not by Cerebrospinal Fluid or Fluid from Tumor Bed in Patients with Malignant Glioma
por: Shimizu, Keiji, et al.
Publicado: (1995)

Drug Repositioning for Refractory Benign Tumors of the Central Nervous System
por: Tamura, Ryota
Publicado: (2023)

Diagnosis of Tumours of the Central Nervous System
por: Cairns, Hugh
Publicado: (1946)

The Diagnosis of Tumours of the Central Nervous System
por: Beck, Diana J. Kinloch
Publicado: (1946)

The PCR-Based Diagnosis of Central Nervous System Tuberculosis: Up to Date
por: Takahashi, Teruyuki, et al.
Publicado: (2012)

The 2007 WHO Classification of Tumours of the Central Nervous System
por: Louis, David N., et al.
Publicado: (2007)

The 2007 WHO classification of tumours of the central nervous system
por: Louis, David N., et al.
Publicado: (2007)

Histological Typing of tumours of the Central Nervous System
por: Dodge, O. G.
Publicado: (1981)

The role of interleukin-6 in central nervous system demyelination
por: Petković, Filip, et al.
Publicado: (2016)

Therapeutic Opportunities of Interleukin-33 in the Central Nervous System
por: Sun, Yun, et al.
Publicado: (2021)

MicroRNA Regulation of Brain Tumour Initiating Cells in Central Nervous System Tumours
por: Garg, Neha, et al.
Publicado: (2015)

Combined modality therapy of central nervous system tumours
por: Rampling, R
Publicado: (2001)

Interleukin 1 of the central nervous system is produced by ameboid microglia
Publicado: (1986)

Interleukin-6, a Major Cytokine in the Central Nervous System
por: Erta, María, et al.
Publicado: (2012)

DNA methylation-based classification of central nervous system tumours
por: Capper, David, et al.
Publicado: (2018)

Increasing incidence of childhood tumours of the central nervous system in Denmark, 1980–1996
por: Raaschou-Nielsen, O, et al.
Publicado: (2006)

Seasonality of birth in children with central nervous system tumours in Denmark, 1970–2003
por: Schmidt, L S, et al.
Publicado: (2009)

A new mouse model of Canavan leukodystrophy displays hearing impairment due to central nervous system dysmyelination
por: Carpinelli, Marina R., et al.
Publicado: (2014)

2007 World Health Organization classification of tumours of the central nervous system
por: Thurnher, Majda M.
Publicado: (2009)

Cerebrospinal Fluid Interleukin-6 in Central Nervous System Inflammatory Diseases
por: Wullschleger, Alexandre, et al.
Publicado: (2013)

The transcriptome of mouse central nervous system myelin
por: Thakurela, Sudhir, et al.
Publicado: (2016)

Interleukin-11 in Pathologies of the Nervous System
por: Airapetov, M. I., et al.
Publicado: (2023)

Detection of human cytomegalovirus genome and gene products in central nervous system tumours
por: Sabatier, J, et al.
Publicado: (2005)

Central Nervous System Infections
por: Archibald, Lennox K., et al.
Publicado: (2013)

The concentration of HCG in the plasma and spinal fluid of patients with trophoblastic tumours in the central nervous system.
por: Rushworth, A. G., et al.
Publicado: (1968)

The molecular pathology of p53 in primitive neuroectodermal tumours of the central nervous system
por: Burns, A S Y W, et al.
Publicado: (2002)

The Central Nervous System
por: De Lorenzi, Davide, et al.
Publicado: (2016)

The Central Nervous System
por: De Lorenzi, Davide, et al.
Publicado: (2010)

Is CD19-directed chimeric antigen receptor T cell therapy a smart strategy to combat central nervous system lymphoma?
por: Miyao, Kotaro, et al.
Publicado: (2023)

The Epidemic Diseases of the Central Nervous System
por: Chalmers, A. K.
Publicado: (1925)

The Epidemic Diseases of the Central Nervous System
por: Chalmers, A. K.
Publicado: (1925)

Tumours of the central nervous system and serum sialic acid concentration in men and women.
por: Gatchev, O., et al.
Publicado: (1993)

School behaviour and health status after central nervous system tumours in childhood.
por: Glaser, A. W., et al.
Publicado: (1997)

Space-time clustering of childhood central nervous system tumours in Yorkshire, UK
por: McNally, Richard JQ, et al.
Publicado: (2012)

Central nervous system tumours in children in Ibadan, Nigeria: a histopathologic study
por: Ogun, Gabriel Olabiyi, et al.
Publicado: (2016)

The 2016 WHO Classification of Tumours of the Central Nervous System: The Major Points of Revision
por: KOMORI, Takashi
Publicado: (2017)

Central Nervous System Demyelination Related to Tumour Necrosis Factor Alpha Inhibitor
por: Chey, Shin Yee, et al.
Publicado: (2022)

REGIONAL DIFFERENCES IN THE SURVIVAL EXPERIENCE OF PATIENTS WITH CENTRAL NERVOUS SYSTEM TUMOURS IN CANADA
por: Wu, Yifan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s91ot5gkl2euokf31b23tip477